Want to join the conversation?
St. Louis, Missouri-based pharmacy company $ESRX said that for 4Q15, it delivered adjusted EPS of $1.56, representing growth of 12% over last year. The company adjudicated 341.5MM adjusted claims generating adjusted EBITDA of $1.9Bil, up 4%, resulting in adjusted EBITDA per claim of $5.66. $ESRX generated $2.9Bil of cash flow in 4Q15.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.